Head to Head Contrast: Zhongchao (NASDAQ:ZCMD) vs. 111 (NASDAQ:YI)

111 (NASDAQ:YI) and Zhongchao (NASDAQ:ZCMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation.

Institutional and Insider Ownership

21.3% of 111 shares are held by institutional investors. Comparatively, 1.7% of Zhongchao shares are held by institutional investors. 43.9% of 111 shares are held by insiders. Comparatively, 28.6% of Zhongchao shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares 111 and Zhongchao’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
111	-0.76%	N/A	-3.80%
Zhongchao	N/A	N/A	N/A

Volatility & Risk

111 has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Zhongchao has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for 111 and Zhongchao, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1	0	0	0	1.00
Zhongchao	1	0	0	0	1.00

Valuation and Earnings

This table compares 111 and Zhongchao”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$1.80 billion	0.02	-$9.65 million	($1.40)	-2.66
Zhongchao	$11.38 million	0.17	-$6.31 million	N/A	N/A

Zhongchao has lower revenue, but higher earnings than 111.

About 111

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

About Zhongchao

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.